Evry, November 11, 2022
Global Bioenergies announces today the renewal of its equity financing line with Kepler Cheuvreux, a leading European financial services company acting as ISP under a bought deal commitment. This financing solution with Kepler Cheuvreux has already proven its worth at Global Bioenergies: the two-year contract signed in August 2020 has raised 13.6 million euros, and over the same period the valuation of Global Bioenergies has doubled. .
This operation aims to strengthen the financial structure of the company and the funds obtained will contribute in particular to the pre-financing of the production of Isonaturane® 12 from the new sector known as “Horizon 2” and to the performance of engineering studies for the Horizon 3 plant with a capacity of 2,000 tonnes per year, the construction of which will be financed via a dedicated project company during 2023. This operation was implemented in accordance with the 12th resolution of the general meeting of shareholders of June 18, 2021.